Risk of pulmonary embolism with high-dose tofacitinib

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-59442-7
中图分类号
学科分类号
摘要
引用
收藏
页码:4 / 4
相关论文
共 50 条
  • [41] High-dose antioxidant supplementation and cataract risk
    Mares, JA
    [J]. NUTRITION REVIEWS, 2004, 62 (01) : 28 - 32
  • [44] High-dose methotrexate and risk factors for intoxication
    Clarivet, B.
    Martinez, A.
    Vincent, L.
    Vergely, L.
    Hicheri, Y.
    Hillaire-Buys, D.
    Cartron, G.
    Mathieu, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 44 - 44
  • [45] HIGH-DOSE STATINS RAISE DIABETES RISK
    Kuznar, Wayne
    [J]. AMERICAN JOURNAL OF NURSING, 2011, 111 (11) : 60 - 60
  • [47] Multiple risk factors for high-dose chemotherapy
    Sarrá, J
    Vivancos, P
    Sola, R
    Grañena, A
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (09) : 933 - 933
  • [48] Multiple risk factors for high-dose chemotherapy
    J Sarrá
    P Vivancos
    R Sola
    A Grañena
    [J]. Bone Marrow Transplantation, 1998, 22 : 933 - 933
  • [49] Risk Associated With High-Dose Bicalutamide Reply
    Stein, Mark N.
    Jang, Thomas L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [50] HIGH-DOSE ULTRA-SHORT FIBRINOLYTIC TREATMENT OF MASSIVE PULMONARY-EMBOLISM WITH STREPTOKINASE IN THE EARLY POSTOPERATIVE PERIOD
    GOLDSTEIN, M
    [J]. ANAESTHESIST, 1987, 36 (05): : 239 - 241